trending Market Intelligence /marketintelligence/en/news-insights/trending/VZeamjBU1diY9981SH0krg2 content esgSubNav
In This List

Rosetta Genomics receives extension to regain compliance with Nasdaq

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Rosetta Genomics receives extension to regain compliance with Nasdaq

Nasdaq granted Rosetta Genomics Ltd. an extension to regain compliance with the exchange's listing requirement.

Under the extension, Rosetta Genomics must close its previously announced acquisition by Genoptix Inc. by April 23, 2018.

In case the deal does not go through, the company must raise equity to comply with the exchange's requirement.